Skip to main content

Functional and Metabolomic Consequences of K Channel Inactivation in Human Islets.

Citation
Li, C., et al. “Functional And Metabolomic Consequences Of K Channel Inactivation In Human Islets.”. Diabetes, pp. 1901-1913.
Center University of Pennsylvania
Featured
Author Changhong Li, Amanda M Ackermann, Kara E Boodhansingh, Tricia R Bhatti, Chengyang Liu, Jonathan Schug, Nicolai Doliba, Bing Han, Karen E Cosgrove, Indraneel Banerjee, Franz M Matschinsky, Itzhak Nissim, Klaus H Kaestner, Ali Naji, Scott Adzick, Mark J Dunne, Charles A Stanley, Diva D De Leon
Abstract

Loss-of-function mutations of β-cell K channels cause the most severe form of congenital hyperinsulinism (KHI). KHI is characterized by fasting and protein-induced hypoglycemia that is unresponsive to medical therapy. For a better understanding of the pathophysiology of KHI, we examined cytosolic calcium ([Ca] ), insulin secretion, oxygen consumption, and [U-C]glucose metabolism in islets isolated from the pancreases of children with KHI who required pancreatectomy. Basal [Ca] and insulin secretion were higher in KHI islets compared with controls. Unlike controls, insulin secretion in KHI islets increased in response to amino acids but not to glucose. KHI islets have an increased basal rate of oxygen consumption and mitochondrial mass. [U-C]glucose metabolism showed a twofold increase in alanine levels and sixfold increase in C enrichment of alanine in KHI islets, suggesting increased rates of glycolysis. KHI islets also exhibited increased serine/glycine and glutamine biosynthesis. In contrast, KHI islets had low γ-aminobutyric acid (GABA) levels and lacked C incorporation into GABA in response to glucose stimulation. The expression of key genes involved in these metabolic pathways was significantly different in KHI β-cells compared with control, providing a mechanism for the observed changes. These findings demonstrate that the pathophysiology of KHI is complex, and they provide a framework for the identification of new potential therapeutic targets for this devastating condition.

Year of Publication
2017
Journal
Diabetes
Volume
66
Issue
7
Number of Pages
1901-1913
Date Published
12/2017
ISSN Number
1939-327X
DOI
10.2337/db17-0029
Alternate Journal
Diabetes
PMID
28442472
PMCID
PMC5482088
Download citation